| scholarly article | Q13442814 |
| P2093 | author name string | Levine JS | |
| Rauch J | |||
| Lieberthal W | |||
| Walsh MT | |||
| Koh JS | |||
| Shia MA | |||
| Price BE | |||
| Gilligan HM | |||
| O'Laughlin T | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | apoptotic process | Q14599311 |
| autoantibody | Q785022 | ||
| thymocyte | Q7799635 | ||
| P304 | page(s) | 2201-2208 | |
| P577 | publication date | 1996-09-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Anti-phospholipid autoantibodies bind to apoptotic, but not viable, thymocytes in a beta 2-glycoprotein I-dependent manner | |
| P478 | volume | 157 |
| Q34896439 | Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study |
| Q35928668 | Anti-phospholipid antibodies (aPL) and apoptosis: prothrombin-dependent aPL as a paradigm for phospholipid-dependent interactions with apoptotic cells |
| Q52552684 | Antiannexin V autoantibody in thrombophilic Behçet's disease. |
| Q24812425 | Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides |
| Q36377451 | Antineutrophil cytoplasmic autoantibodies interact with primary granule constituents on the surface of apoptotic neutrophils in the absence of neutrophil priming |
| Q36300619 | Antiphospholipid antibodies are associated with enhanced oxidative stress, decreased plasma nitric oxide and paraoxonase activity in an experimental mouse model |
| Q28364192 | Antiphospholipid antibodies associated with alcoholic liver disease specifically recognise oxidised phospholipids |
| Q35775322 | Antiphospholipid syndrome: multiple mechanisms |
| Q79874220 | Apoptosis and autoimmunity |
| Q34250889 | Apoptosis, clearance mechanisms, and the development of systemic lupus erythematosus. |
| Q36399652 | Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory |
| Q40975353 | Beta2-glycoprotein I (beta2-GPI) mRNA is expressed by several cell types involved in anti-phospholipid syndrome-related tissue damage |
| Q29026902 | CD4 depletion in HIV-infected haemophilia patients is associated with rapid clearance of immune complex-coated CD4+ lymphocytes |
| Q73223383 | Cardiolipin on the surface of apoptotic cells as a possible trigger for antiphospholipids antibodies |
| Q33699448 | Clearance: the last and often forgotten stage of apoptosis |
| Q38078691 | Dendritic cells: an important link between antiphospholipid antibodies, endothelial dysfunction, and atherosclerosis in autoimmune and non-autoimmune diseases |
| Q89158649 | Different domains of β2-glycoprotein I play a role in autoimmune pathogenesis |
| Q64966940 | Human monoclonal anti-phospholipid antibodies selectively bind to membrane phospholipid and beta2-glycoprotein I (beta2-GPI) on apoptotic cells. |
| Q24673242 | I-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation |
| Q36227184 | Immunization with an apoptotic cell-binding protein recapitulates the nephritis and sequential autoantibody emergence of systemic lupus erythematosus |
| Q35604834 | Interaction of β2-glycoprotein I with lipopolysaccharide leads to Toll-like receptor 4 (TLR4)-dependent activation of macrophages |
| Q37384485 | Lysophosphatidic acid is a major serum noncytokine survival factor for murine macrophages which acts via the phosphatidylinositol 3-kinase signaling pathway |
| Q37207643 | Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition |
| Q34649313 | Phagocytosis of opsonized apoptotic cells: roles for 'old-fashioned' receptors for antibody and complement |
| Q42034633 | Quantitative determination of the binding of beta2-glycoprotein I and prothrombin to phosphatidylserine-exposing blood platelets |
| Q37059648 | Role of nucleic acid-sensing TLRs in diverse autoantibody specificities and anti-nuclear antibody-producing B cells |
| Q33950104 | Structural basis for autoantibody recognition of phosphatidylserine-beta 2 glycoprotein I and apoptotic cells |
| Q34445583 | Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice |
| Q35148616 | Systemic lupus erythematosus and apoptosis: a question of balance |
| Q59651722 | The Rubino test for leprosy is a beta2-glycoprotein 1-dependent antiphospholipid reaction |
| Q37721589 | The dual role of innate immunity in the antiphospholipid syndrome |
| Q36213428 | The persistence of anticardiolipin antibodies is associated with an increased risk of the presence of lupus anticoagulant and anti-beta2-glycoprotein I antibodies |
| Q36229639 | The presence of multiple prothrombotic risk factors is associated with a higher risk of thrombosis in individuals with anticardiolipin antibodies |
| Q33355589 | The thrombophilic network of autoantibodies in celiac disease |
| Q55547645 | Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies. |
| Q39808627 | beta2-glycoprotein-I (apolipoprotein H) and beta2-glycoprotein-I-phospholipid complex harbor a recognition site for the endocytic receptor megalin |
| Q60961044 | β2-Glycoprotein I-Reactive T Cells in Autoimmune Disease |
| Q35126642 | β2-Glycoprotein I-specific T cells are associated with epitope spread to lupus-related autoantibodies |
Search more.